Dissociative anesthetic and benzodiazepine combination

This page covers all Dissociative anesthetic and benzodiazepine combination drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting NMDA receptor (ketamine); GABA-A receptor (midazolam).

Targets

NMDA receptor (ketamine); GABA-A receptor (midazolam)

Marketed (2)

• KETAMINE, MIDAZOLAM · Soroka University Medical Center · Anesthesia and Sedation
  Ketamine and midazolam together provide dissociative anesthesia and sedation by blocking NMDA receptors and enhancing GABAergic inhibition, respectively.
• Ketamine and Midazolam · Kanuni Sultan Suleyman Training and Research Hospital · Anesthesia and Sedation
  Ketamine and midazolam together provide dissociative anesthesia and sedation by blocking NMDA receptors and enhancing GABAergic inhibition, respectively.